Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Timber Pharmaceuticals Inc. TMBR

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSEAM:TMBR)

Fundamentals Snapshot (NYSEAM:TMBR)

Opinion & Analysis (NYSEAM:TMBR)

No current opinion is available.

Bullboard Posts (NYSEAM:TMBR)

News

After hours news, company to approach FDA about ending Phase 2a/b trial based on favourable results in enrolled patients.  Looking...
ok2buy - May 26, 2021

Morningstar

Morningstar as of May 19, 21 giving TMBR a fair valuation of $1.51/share.  Trading at a discount to that valuation.  This won...
ok2buy - May 21, 2021

RE:BOOM!

Things are looking good from now on. Next stop $12. Very soon!!!!
MMiskw - March 30, 2021

BOOM!

going UP !
WakeUPP - January 20, 2021